Taste masking of metoclopramide hydrochloride by novel melt granulation

International Journal of Drug Delivery

Volumn 4, Issue 1, 2012, Pages 89-94

  Ahire, S B ^a   Gaikwad, P D ^a   Bankar, V H ^a   Pawar, S P ^a  

^a PSGVPM's College of Pharmacy   (India)

Author keywords

Glycerol monostearate; Melt granulation; Metoclopramide HCL; Taste masking

Indexed keywords

GLYCEROL STEARATE; METOCLOPRAMIDE;

ARTICLE; BITTER TASTE; CHEMICAL PROCEDURES; DIFFERENTIAL SCANNING CALORIMETRY; DRUG GRANULATION; DRUG QUALITY; DRUG SCREENING; FEMALE; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; MELT GRANULATION; NORMAL HUMAN; ORGANOLEPTIC PROPERTY; TASTE DISCRIMINATION; ADULT; COMPLEX FORMATION; PARTICLE SIZE; SURFACE PROPERTY; TASTE;

EID: 84871263586     PISSN: None     EISSN: 09754415     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Shimano K, Kondo O, Miwa A, Higashi Y, Goto S. Evaluation of uniform-sized microcapsules using a vibration-nozzle method. Drug Dev. Ind. Pharm. 1995: 21: 331-347.
2. Amrutkar PP, Patil SB. Design and evaluation of taste masked chewable dispersible tablet of Lamotrigine by melt granulation. Int. J of Drug Delivery. 2010:Volume 2: 183-191.
3. Lachman L, Liberman HA, Kanig JL. In The theory and practice of Industrial Pharmacy.3rd ed, Marcel Dekker, Bombay, 1991: 374.
4. Mohore JG, Wadher KJ, Umekar MJ. Taste abatement of metoclopramide hydrochloride using ion exchange resins. Scholars research library, 2009:1(2) 164-171.
5. Blase CM, Shaw MN. Aqueous pharmaceutical suspensions for pharmaceutical actives. 1993: EP application no. O556057 B1 to McNeil- PPC Inc.
6. Appelgren C, Eskilson C. Novel method for the granulation and coating of pharmacologically active substance. Drug. Dev. Ind. Pharm. 1990: 16: 2345-2351.
7. th edition, published on recommendation of Medicines Commission, 2005: 3924-3928.
8. Aloorkar NH, Bhatia MS, Rapidly disintegrating tablets of metoclopramide hydrochloride using novel chemically modified cellulose. Ars Pharmaceutica 2011: 52 (3):26-27.
9. Frutos P, Pabon C, Lastres JL, Frutos G. In vitro release of metoclopramide from hydrophobic matrix tablets influence of hydrodynamic conditions on kinetic release parameters.Chem. Pharm. Bull. 2001: 10: 1267-1271.
10. Hasan EI, Amro BI, Arafat T, Badwan AA. Assessment of a controlled release hydrophilic matrix formulation for metoclopramide HCl. Eur. J. Pharm. Biopharm. 2003: 55: 339-344.
11. Schaefer T. Melt agglomeration with polyethylene glycols in high shear mixer. Ph.D. thesis, The Royal Danish School of Pharmacy, Denmark. 1997.
12. Thies R, Kleinebudde P, Melt pelletisation of a hygroscopic drug in a high shear mixer. Part 1. Influence of process variables, Int. J Pharm. 1999: 188: 131-143.
13. Zhou F, Vervaet C, Remon JP. Matrix pellets on the combination of waxes, starches and maltodextrins. Int. J Pharm. 1996: 133: 155-160.
14. Voinovich D, Moneghini M, Perissutti B, Filipovic-Grcic J, Grabnar I. Preparation in high-shear mixer of sustained-release pellets by melt pelletisation. Int. J Pharm. 2000: 203: 235-244.
15. Perissutti B, Voinovich D, Moneghini M, Franceschinis E. A powerful technique to prepare in a single step potential sustained release dosage forms: melt pelletisation in high shear mixer. In: Fourth World Meeting on Pharmaceutics BiopharmaceuticsPharmaceutical Technology, Florence. 2002.